The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
2SEVENTY BIO INC | COMMON STOCK | 901384107 | 5,823 | 341,302 | SH | SOLE | 341,302 | 0 | 0 | ||
ACADIA PHARMACEUTICALS INC | COM | 004225108 | 6,031 | 249,000 | SH | SOLE | 249,000 | 0 | 0 | ||
ALTUS POWER INC | COM CL A | 02217A102 | 2,659 | 357,849 | SH | SOLE | 357,849 | 0 | 0 | ||
APARTMENT INVT & MGMT CO | CL A | 03748R747 | 72,703 | 9,932,043 | SH | SOLE | 9,932,043 | 0 | 0 | ||
APELLIS PHARMACEUTICALS INC | COM | 03753U106 | 7,571 | 149,000 | SH | SOLE | 149,000 | 0 | 0 | ||
ARCUS BIOSCIENCES INC | COM | 03969F109 | 5,712 | 181,000 | SH | SOLE | 181,000 | 0 | 0 | ||
ASCENDIS PHARMA A/S | SPONSORED ADR | 04351P101 | 6,866 | 58,500 | SH | SOLE | 58,500 | 0 | 0 | ||
AT&T INC | COM | 00206R102 | 264,341 | 11,186,667 | SH | SOLE | 11,186,667 | 0 | 0 | ||
AT&T INC | COM | 00206R102 | 23,630 | 1,000,000 | SH | Call | SOLE | 1,000,000 | 0 | 0 | |
BRAEMAR HOTELS & RESORTS INC | COM | 10482B101 | 160 | 25,951 | SH | SOLE | 25,951 | 0 | 0 | ||
CELLDEX THERAPEUTICS INC NEW | COM NEW | 15117B202 | 7,221 | 212,000 | SH | SOLE | 212,000 | 0 | 0 | ||
CHEMOURS CO | COM | 163851108 | 221,254 | 7,028,398 | SH | SOLE | 7,028,398 | 0 | 0 | ||
COINBASE GLOBAL INC | COM CL A | 19260Q107 | 37,972 | 200,000 | SH | Put | SOLE | 200,000 | 0 | 0 | |
CONCORD ACQUISITION CORP | COM CL A | 206071102 | 4,975 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
CORTEVA INC | COM | 22052L104 | 100,538 | 1,749,092 | SH | SOLE | 1,749,092 | 0 | 0 | ||
CRISPR THERAPEUTICS AG | NAMEN AKT | H17182108 | 6,779 | 108,000 | SH | SOLE | 108,000 | 0 | 0 | ||
DISCOVERY INC | COM SER A | 25470F104 | 32,620 | 1,308,999 | SH | SOLE | 1,308,999 | 0 | 0 | ||
DISCOVERY INC | COM SER C | 25470F302 | 112,842 | 4,519,093 | SH | SOLE | 4,519,093 | 0 | 0 | ||
DISH NETWORK CORPORATION | CL A | 25470M109 | 12,926 | 408,399 | SH | SOLE | 408,399 | 0 | 0 | ||
DT MIDSTREAM INC | COMMON STOCK | 23345M107 | 50,817 | 936,548 | SH | SOLE | 936,548 | 0 | 0 | ||
EQUITABLE HLDGS INC | COM | 29452E101 | 114,661 | 3,709,521 | SH | SOLE | 3,709,521 | 0 | 0 | ||
FAR PEAK ACQUISITION CORP | SHS CL A | G3312L103 | 5,134 | 516,536 | SH | SOLE | 516,536 | 0 | 0 | ||
FLEX LTD | ORD | Y2573F102 | 46,375 | 2,500,000 | SH | SOLE | 2,500,000 | 0 | 0 | ||
GALAPAGOS NV | SPON ADR | 36315X101 | 5,086 | 82,000 | SH | SOLE | 82,000 | 0 | 0 | ||
GARRETT MOTION INC | COM | 366505105 | 49,699 | 6,912,204 | SH | SOLE | 6,912,204 | 0 | 0 | ||
GARRETT MOTION INC | PFD CONV SER A | 366505204 | 137,219 | 16,592,384 | SH | SOLE | 16,592,384 | 0 | 0 | ||
GORES GUGGENHEIM INC | CLASS A COM | 38286Q107 | 11,370 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | ||
INTERNATIONAL FLAVORS&FRAGRA | COM | 459506101 | 91,149 | 694,043 | SH | SOLE | 694,043 | 0 | 0 | ||
JACKSON FINANCIAL INC | COM CL A | 46817M107 | 39,948 | 903,188 | SH | SOLE | 903,188 | 0 | 0 | ||
MACROGENICS INC | COM | 556099109 | 2,157 | 244,864 | SH | SOLE | 244,864 | 0 | 0 | ||
NXP SEMICONDUCTORS N V | COM | N6596X109 | 20,739 | 112,053 | SH | SOLE | 112,053 | 0 | 0 | ||
ORION OFFICE REIT INC | COM | 68629Y103 | 63,214 | 4,515,253 | SH | SOLE | 4,515,253 | 0 | 0 | ||
PRIMO WATER CORPORATION | COM | 74167P108 | 28,244 | 1,982,040 | SH | SOLE | 1,982,040 | 0 | 0 | ||
PROTAGONIST THERAPEUTICS INC | COM | 74366E102 | 6,086 | 257,000 | SH | SOLE | 257,000 | 0 | 0 | ||
PROTHENA CORP PLC | SHS | G72800108 | 6,839 | 187,000 | SH | SOLE | 187,000 | 0 | 0 | ||
PROVENTION BIO INC | COM | 74374N102 | 43,920 | 6,000,000 | SH | SOLE | 6,000,000 | 0 | 0 | ||
RELAY THERAPEUTICS INC | COM | 75943R102 | 9,015 | 301,200 | SH | SOLE | 301,200 | 0 | 0 | ||
RXSIGHT INC | COM | 78349D107 | 2,034 | 164,282 | SH | SOLE | 164,282 | 0 | 0 | ||
TESLA INC | COM | 88160R101 | 343,970 | 319,200 | SH | Put | SOLE | 319,200 | 0 | 0 | |
UNITEDHEALTH GROUP INC | COM | 91324P102 | 41,053 | 80,500 | SH | Put | SOLE | 80,500 | 0 | 0 | |
VAREX IMAGING CORP | COM | 92214X106 | 24,197 | 1,136,566 | SH | SOLE | 1,136,566 | 0 | 0 | ||
VELOCITY ACQUISITION CORP | COM CL A | 92259E104 | 3,906 | 400,650 | SH | SOLE | 400,650 | 0 | 0 | ||
XERIS BIOPHARMA HOLDINGS INC | NOTE 5.000% 7/1 | 98422LAA5 | 11,690 | 9,975,000 | PRN | SOLE | 9,975,000 | 0 | 0 |